Today’s guest on the ValueTheMarkets podcast is Dr Ray Barlow, CEO of E-Therapeutics (LSE:ETX). The company is employing a computer-based approach to the discovery of new drugs. It’s Network-Driven Discovery (NDD) platform employs techniques such as machine learning, artificial intelligence, and data analysis to find better drug solutions in a more efficient manner.
In the interview, Ray discusses the NDD platform, the company’s business model, the changes he’s made since joining the board in 2017, and talks about his background in the industry.
